Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Vir’s clinical-stage portfolio includes infectious disease programs for chronic hepatitis delta and chronic hepatitis B infections, in addition to multiple oncology programs. Vir also has a preclinical portfolio of programs across a range of other infectious diseases and oncologic malignancies.
We believe the success of our colleagues drives the success of our mission. We are committed to creating a company passionate about equality, inclusion, and respect. When everyone feels supported and encouraged to give their best, we will collectively deliver outstanding results.
The Head of Marketing will drive both the global commercial product strategy and implementation for the VIR portfolio. Reporting directly to the SVP, Commercial, you will help develop and deliver Vir’s commercial strategies and marketing plans for the company’s lead Hepatitis program(s) in preparation for anticipated launches.
In this highly collaborative role, you will sit on the Hepatitis Program team, lead the BCT (Business Commercial Team), and sit on multiple other cross-functional teams, representing commercial and/or Hepatitis leadership. You will partner with Program Executives/Teams, Medical Affairs, Legal, Manufacturing, Advocacy, Finance, CI, etc. to drive the planning and execution of strategies across Marketing, Patient Support, Market Access, Distribution, Advocacy/Health Policy, and Field Strategy. As an integral member of the Commercial team, you will inform commercial product strategy more broadly across the VIR portfolio.
This role is located in our San Francisco headquarters with an expectation of 4 days per week in office.
WHAT YOU'LL DO
- Lead the creation of the global brand plan and oversee the development and execution of the tactical plan in support of the overall brand strategy
- Oversee pre-launch positioning and key message planning as well as post-launch tactical planning and implementation for Vir’s inline products
- Maintain and modify our commercial launch readiness playbook; bring creative thinking in go-to-market approaches
- Build integrated global strategic plans and budgets that meet market, regulatory, commercial and enterprise needs. Work with functional counterparts to achieve those plans and budgets
- Be a key stakeholder in the refinement of forecasts, commercial budgets, and P&L for collaborations/products/programs
- Develop and execute US launch campaigns, and global where applicable, including the development of a differentiating strategy, unique branding, compelling positioning and key messaging that maintain or extend our global market position
- Shape, maintain and update the brand profile and develop key marketing deliverables, including value proposition, messaging, positioning, differential advantages, brand book and, in coordination with strategic partners to maximize revenue potential while ensuring strategic alignment and meeting patient needs
- Conduct strategic marketing activities including market and competitive research and product positioning in close collaboration with cross commercial disciplines and partners as appropriate. Identify actionable insights based on market research and ensure that the product/brand addresses areas of unmet need. Ensure KPIs are relevant and informative for brand and patient objectives
- Participate in portfolio prioritization and life cycle planning activities for relevant clinical-stage programs
- 12+ years of relevant in-line commercial experience at an early-stage biotech and/or pharmaceutical company, preferably in both large and small companies, developing and executing launch strategies
- B.A./ B.S. and MBA and/or advanced degree required
- Substantial experience in product strategic planning, including developing differentiated brand positioning and messaging, as well as deep in-line experience, both pre-launch and post-launch
- Any of the following experiences would be a plus: rare disease, building new markets/new therapeutic area commercialization and/or market development/activation experience
- Working knowledge of current US payer environment and dynamics, including patient affordability programs
- Strong analytical skills, demonstrated by the ability to identify and interpret complex issues and provide appropriate recommendations to senior management and across functional areas, including key market planning insights based on epi data and market research
- Previous experience attracting, developing and retaining high caliber leaders and contributors that help build and shape the business to drive future success of the organization
- Strong developmental leader who leverages this skillset to create a high performing organization
- Ability to travel as required to meet business needs
- Must plan to be in-office 4 days per week
#LI-225024411_AA1
#LI-Onsite
The expected salary range for this position is $225,000 to $329,500. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors.
Vir’s compensation and benefits are aligned with the current market and commensurate with the person’s experience and qualifications. All full-time employees receive a package that includes compensation, bonus and equity as well as many other Vir benefits and perks such as health, dental, vision, life and disability insurance benefits, non-accrual paid time off, company shut down for holidays, commuter benefits, childcare reimbursement, education reimbursement, 401K match and lunch each day in the office.
Applicants must currently be authorized to work for any employer in the U.S. We are unable to sponsor or take over sponsorship of an employment Visa at this time.
Vir Biotechnology (“Vir”) is an equal opportunity employer. All employment decisions at Vir are based on legitimate, non-discriminatory business requirements, job duties and individual qualifications. Employment decisions are made without regard to race, color, religion, sex (including pregnancy), gender, gender identity, gender expression, sexual orientation, age, parental status, marital status, national origin, ancestry, disability, medical condition, genetic information (including family medical history), political affiliation, military service or any other legally protected characteristic.
This commitment extends to all management practices and decisions, including recruitment and hiring, compensation, appraisal systems, promotions, training and career development programs. Vir also strongly commits to providing employees with a work environment free of unlawful discrimination or harassment.
Vir Human Resources leads recruitment and employment for Vir. Unsolicited resumes sent to Vir from recruiters do not constitute any type of relationship between the recruiter and Vir and do not obligate Vir to pay fees should we hire from those resumes. We ask that external recruiters and/or agencies not contact or present candidates directly to our hiring manager or employees.
For hires based in the United States, Vir Biotechnology, Inc., participates in E-Verify.
Candidate Privacy Notice
What We Do
Vir Biotechnology, Inc. (in Europe, Humabs BioMed, https://bit.ly/46lQGN2) is an immunology company focused on powering the immune system to address unmet patient needs in infectious disease and beyond. Our powerful R&D engine combines our proprietary monoclonal antibody (mAb) platform with machine learning and artificial intelligence-enhanced capabilities, enabling us to engineer our rich database of human antibodies and deliver transformative medicines for diseases with significant global burden.
Our current pipeline consists of multiple clinical candidates targeting hepatitis B and hepatitis delta viruses and human immunodeficiency virus, including a potential functional cure for chronic hepatitis B and treatment for chronic hepatitis delta. Our portfolio of broad, potent investigational monoclonal antibodies also targets influenza A and B viruses, COVID-19, respiratory syncytial virus/human metapneumovirus and human papillomavirus, and our investigational T cell vaccine aims to prevent HIV. Explore our full pipeline: https://bit.ly/3tr7FPm
We collaborate with some of the world’s leaders in industry as well as government agencies and non-profit organizations enabling us to rapidly advance cutting-edge scientific discoveries and innovative technologies with the potential to benefit people around the world.
We are proud to have been ranked the fastest-growing company in North America on the 2022 Deloitte Technology Fast 500™.
Join us as we pursue our mission to transform lives.
It has come to our attention that there have been various recruitment scams targeting job seekers on LinkedIn. Vir Biotechnology, Inc. is committed to your privacy and will never request sensitive personal information including banking details through email, text message, social media or video software platforms. We also will never request a financial commitment from a candidate as part of the application process. Learn more about Vir’s recruiting process: https://bit.ly/461EgJN
